Tasly Capital
Overview
Tasly Capital is a corporate venture capital arm of Tasly Holding Group that invests in the healthcare industry, including biotechnology, drug discovery, and medical devices.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lingbo Biotechnology (Hangzhou) Co., Ltd. | Jun 2024 | Series A Extension | Lead |
| Hangzhou Lead Biotech Co., Ltd. | Jun 2024 | Series A Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Tasly Capital based?
Tasly Capital is headquartered in Beijing, China.
When was Tasly Capital founded?
Tasly Capital was founded in 2007.
How many portfolio companies does Tasly Capital have?
Tasly Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Tasly Capital's portfolio?
Portfolio companies visible on Caplight include Lingbo Biotechnology (Hangzhou) Co., Ltd., Hangzhou Lead Biotech Co., Ltd..
What was Tasly Capital's most recent investment shown here?
Tasly Capital's most recent investment in this portfolio sample was in Hangzhou Lead Biotech Co., Ltd. in 2024.
What sectors does Tasly Capital focus on?
Tasly Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Tasly Capital focus on?
Tasly Capital typically invests at the Early stage.